300510
By:
Yu Shen
|
9:35 AM 08/12/2002
|
Sample Size Re-estimation for Clinical Trials with Censored Survival Data
|
300304
By:
Reena Deutsch
|
2:35 PM 08/13/2002
|
"What sample size do I need?"...or...A biostatistical consultant's roles as an educator
|
300589
By:
H.M. James Hung
|
2:05 PM 08/12/2002
|
Adaptive Statistical Inference Following Sample Size Modification Based on Interim Review of Effect Size
|
300599
By:
Cunshan Wang
|
9:05 AM 08/14/2002
|
Sample Size Re-estimation for Binary Data via Conditional Power
|
300136
By:
Qing Liu
|
9:15 AM 08/12/2002
|
General Two-Stage Adaptive Designs With Dependent Data
|
300692
By:
Michael R. Jiroutek
|
2:05 PM 08/14/2002
|
Using Estimates to Choose a Sample Size for Confidence Intervals With Good Properties
|
300722
By:
Gene A. Pennello
|
4:05 PM 08/11/2002
|
Sample Size for Repeated Measures Designs of Method Comparisons
|
300723
By:
Sharon C. Murray
|
08/13/2002
|
Poster # 14
An Application of a Multi-Stage Strategy Involving Confidence Intervals to Evaluate Whether a Response Rate is Favorable or Not
|
300724
By:
T. Sriram
|
3:05 PM 08/14/2002
|
300782
By:
Tze-San D. Lee
|
10:50 AM 08/15/2002
|
On Determination of Sample Size for the Positive Kappa Coefficient
|
300225
By:
Sherryl Baker
|
2:30 PM 08/11/2002
|
Statistical Issues in Clinical Trials Involving Drug Addicted Patients
|
300383
By:
James Ware
|
2:55 PM 08/13/2002
|
Bridging and Global Drug Development: A Regional Strategy
|
301000
By:
Mani Y. Lakshminarayanan
|
11:20 AM 08/13/2002
|
Use of Hazard Ratio in Comparing Survival Distributions
|
300082
By:
Mike Proschan
|
2:25 PM 08/12/2002
|
Practical Mid-Course Sample Size Modification In Clinical Trials
|
300260
By:
Christopher Jennison
|
3:05 PM 08/12/2002
|
Flexible Sample Size: Still No Free Lunch!
|
301027
By:
Craig Wood
|
08/13/2002
|
Poster # 07
Sample Size Requirements for Comparing Two Populations with DNA Microarray Analyses of Gene Expression: A Monte Carlo Method
|
301106
By:
Peng T. Liu
|
11:05 AM 08/14/2002
|
The Optimal Strategy in Designing a Case-Control Study
|
301136
By:
Cynthia O. Siu
|
2:50 PM 08/11/2002
|
Bridging Studies: Design and Analysis Issues
|
301178
By:
Yi Cheng
|
11:35 AM 08/12/2002
|
Asymptotic Optimal Sample Sizes for Discovering Promising Treatment in Phase II Group Sequential Clinical Trials.
|
301212
By:
Keunpyo Kim
|
10:05 AM 08/15/2002
|
The MEWMA Control Chart When Different Variables Have Different Sample Sizes
|
301233
By:
James J. Grady
|
08/12/2002
|
Poster # 08
Strategies for Writing Statistical Sections for Grant Applications
|
301281
By:
Sin-Ho Jung
|
4:20 PM 08/11/2002
|
Sample Size Estimation for GEE Method for Comparing Slopes in Repeated Measurements Data
|
301649
By:
Joyce L. Burcham
|
08/13/2002
|
Poster # 08
Sample Size for Microarray Gene Expression Comparisons: An Estimation Method of Discrimant Score
|
301704
By:
Marc W. Zodet
|
9:15 AM 08/14/2002
|
Evaluation of the Capacity for More Detailed Analyses of Geographic Variation in Select Healthcare Measures Using the Medical Expenditure Panel Survey
|
301725
By:
David Swanson
|
9:50 AM 08/14/2002
|
Determining Within-PSU Sample Sizes for the Consumer Expenditure Survey
|
300089
By:
Robert Elston
|
2:55 PM 08/13/2002
|
The Study of Candidate Genes in Drug Trials: Sample Size Considerations
|
301752
By:
Chih-Chin Ho
|
11:35 AM 08/12/2002
|
Using Bootstraps to Evaluate the Effect of Sample Size Reduction on Scoring System Performance
|
300083
By:
Cyrus Mehta
|
2:45 PM 08/12/2002
|
Flexible Sample Size Considerations Using Information Based Interim Monitoring
|
301945
By:
David Carlin
|
11:50 AM 08/14/2002
|
On Monte Carlo Simulations in New Drug Development
|
300089
By:
Robert Elston
|
2:55 PM 08/13/2002
|
The Study of Candidate Genes in Drug Trials: Sample Size Considerations
|
300134
By:
Gernot Wassmer
|
8:35 AM 08/12/2002
|
Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
|
|